NEWDIGS is an exciting and innovative approach to developing solutions for systemwide impediments to biomedical innovation and patient care. The noncompetitive, collaborative environment encourages novel and fresh ideas and interactions to … Read More
Dr Gigi Hirsch speaks on Milken Institute Future Health Summit
On October 29 Dr Hirsch participated in a panel discussion titled, “Flipping the Script: Designing the System to Deliver for Patients” in Washington, DC. The diverse panel covered the challenges … Read More
NEWDIGS welcomes new team members
Karen Katz, JD Director, FoCUS Project Ms. Katz joins the NEWDIGS team as Director of the FoCUS Project. Prior to joining NEWDIGS, she was Director, Intellectual Property Programs, Suffolk University … Read More
Advancing Healthcare through Innovation and Collaboration
An Interview with Gigi Hirsch, MD for Evidera | PPD publication: The Evidence Forum Dr Gigi Hirsch and Dr Debra Schaumberg, Vice President, Scientific Affairs, Real-World Evidence at Evidera, discuss the … Read More
Payer Perspectives on Financing and Reimbursement of One-time High-cost Durable Treatments
An online 15-question survey was conducted with clinical and financial health plan leaders from US payers between September 2018 and April 2019. The survey was focused on assessing payer perspectives … Read More
Tracking Medicaid Coverage of Durable Cell and Gene Therapies
Durable cell and gene therapies represent a unique challenge to the US healthcare insurer/payer landscape, given the one-time treatment and associated high upfront cost but potentially durable outcomes. This study … Read More
Transforming Real-World Evidence in Biomedical Innovation: Advancing the Design of Collaborative Disease-Focused Learning Ecosystems
The LEAPS methodology begins by answering two structured questions – WHAT evidence to produce, and HOW to produce it, as outlined in this two-part Research Brief series: • Part I: … Read More
The Role of Stop-Loss Insurance and Reinsurance in Managing Performance-Based Agreements
Over the last decade, rising healthcare costs and the availability of expensive new treatment options has led to a substantial increase in the number of patients with large insurance claims. … Read More
State Insurance Regulations Regarding Benefit Design (Deductible and Co-Pay Waivers)
FoCUS has identified an issue that may be a barrier to timely patient access to durable therapies. The advent of expensive, one-time durable therapies will require changes in private payer … Read More
Baking the Cake: A decision driven framework for planning fit-forpurpose evidence across stakeholders
The LEAPS methodology begins by answering two structured questions: what evidence to produce, and how to produce it, as outlined in this two-part Research Brief series: • Part I: Baking … Read More